Cartesian Therapeutics, a biotech seeking to develop mRNA cell therapies for autoimmune diseases, was trading nearly 20% lower early in Tuesday’s trading. 3 July 2024
Accord BioPharma—the US specialty division of Intas Pharmaceuticals— has won US Food and Drug Administration (FDA) approval for Hercessi (trastuzumab-strf), a b 9 May 2024
Swiss generic and biosimilar medicines company Sandoz has reached agreement with US biotech major Amgen to resolve all patent disputes between the two companies 30 April 2024
Former Italian Prime Minister Enrico Letta has stressed the importance of access to medicines in a report on what is next for Europe’s single market. 19 April 2024
A division of Medicines for Europe, the trade group representing the generics and biosimilars in the region, has called for a new strategy to tackle problems fa 18 April 2024
The Icelandic-Israeli pairing of Alvotech and Teva Pharmaceutical Industries have announced that the US Food and Drug Administration (FDA) has approved Selarsdi 17 April 2024
Germany’s Fresenius—via its operating company Fresenius Kabi—has announced the immediate US availability of Tyenne (tocilizumab-aazg), a biosimilar of Roche’s ( 16 April 2024